Histone Butyrylation/ Acetylation Remains Unchanged in Triple Negative Breast Cancer Cells After a Long Term Metabolic Reprogramming

Asian Pacific Journal of Cancer Prevention
doi 10.31557/apjcp.2019.20.12.3597
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EpiSmart Science Vector Ltd

Related search

Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer

Cancer Discovery
Oncology
2017English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2016English

Triple-Negative Breast Cancer

2018English

TMEPAI Genome Editing in Triple Negative Breast Cancer Cells

Medical Journal of Indonesia
Medicine
2017English

Metabolic Consequences of HIF Silencing in a Triple Negative Human Breast Cancer Xenograft

Oncotarget
Oncology
2018English

Immediate and Long-Term Outcomes of Drug Treatment in Patients With Metastatic Triple Negative Breast Cancer

Malignant tumours
2018English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy